Development of Assays for Nuclear Receptor Modulators Using Fluorescently Tagged Proteins

Methods in Enzymology

Volumn 414, Issue , 2006, Pages 37-50

  Martinez, Elisabeth D ^a   Hager, Gordon L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; GREEN FLUORESCENT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASMID DNA; RESTRICTION ENDONUCLEASE; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CAENORHABDITIS ELEGANS; CELL CULTURE; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CYTOPLASM; DNA BINDING; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HIGH THROUGHPUT SCREENING; LIGAND BINDING; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TRANSCRIPTION INITIATION;

EID: 33750795684     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)14003-3     Document Type: Chapter

References (18)

1. Botos J., Xian W., Smith D.F., and Smith C.L. Progesterone receptor deficient in chromatin binding has an altered cellular state. J. Biol. Chem. 279 (2004) 15231-15239
2. Crescenzi A., Graziano M.F., Carosa E., Papini E., Rucci N., Nardi F., Trimboli P., Calvanese A., Jannini E.A., and D'Armiento M. Localization and expression of thyroid hormone receptors in normal and neoplastic human thyroid. J. Endocrinol. Invest. 26 (2003) 1008-1012
3. de Lange P., Koper J.W., Huizenga N.A., Brinkmann A.O., de Jong F.H., Karl M., Chrousos G.P., and Lamberts S.W. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol. Endocrinol. 11 (1997) 1156-1164
4. Hager G.L. Studying nuclear receptors with green fluorescent protein fusions. Methods Enzymol. 302 (1999) 73-84
5. Kato Y., Ying H., Willingham M.C., and Cheng S.Y. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Endocrinology 145 (2004) 4430-4438
6. Mackem S., Baumann C.T., and Hager G.L. A glucocorticoid/retinoic acid receptor chimera that displays cytoplasmic/nuclear translocation in response to retinoic acid: A real time sensing assay for nuclear receptor ligands. J. Biol. Chem. 276 (2001) 45501-45504
7. Martinez E.D., Dull A.B., Beutler J.A., and Hager G.L. High-content fluorescence-based screening for epigenetic modulators. Methods Enzymol. 414 (2006) (this volume)
8. Martinez E.D., Rayasam G.V., Dull A.B., Walker D.A., and Hager G.L. An estrogen receptor chimera senses ligands by nuclear translocation. J. Steroid Biochem. Mol. Biol 97 4 (2005) 307-321
9. Muscatelli F., Strom T.M., Walker A.P., Zanaria E., Recan D., Meindl A., Bardoni B., Guioli S., Zehetner G., Rabl W., et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372 (1994) 672-676
10. Nishigori H., Tomura H., Tonooka N., Kanamori M., Yamada S., Sho K., Inoue I., Kikuchi N., Onigata K., Kojima I., Kohama T., Yamagata K., Yang Q., Matsuzawa Y., Miki T., Seino S., Kim M.Y., Choi H.S., Moore D.D., Lee Y.K., and Takeda J. Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc. Natl. Acad. Sci. USA 98 (2001) 575-580
11. Shi X.B., Ma A.H., Xia L., Kung H.J., and Vere White R.W. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 62 (2002) 1496-1502
12. Smith C.L., Archer T.K., Hamlin-Green G., and Hager G.L. Newly expressed progesterone receptor cannot activate stable, replicated mouse mammary tumor virus templates but acquires transactivation potential upon continuous expression. Proc. Natl. Acad. Sci. USA 90 (1993) 11202-11206
13. Tajima T., Kitagawa H., Yokoya S., Tachibana K., Adachi M., Nakae J., Suwa S., Katoh S., and Fujieda K. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J. Clin. Endocrinol. Metab. 85 (2000) 4690-4694
14. Van Maldergem L., Bachy A., Feldman D., Bouillon R., Maassen J., Dreyer M., Rey R., Holm C., and Gillerot Y. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Mullerian ducts in a Turkish boy born to consanguineous parents. Am. J. Med. Genet. 64 (1996) 506-513
15. Walker D., Htun H., and Hager G.L. Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods 19 (1999) 386-393
16. Wan Y., Coxe K.K., Thackray V.G., Housley P.R., and Nordeen S.K. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor. Mol. Endocrinol. 15 (2001) 17-31
17. Yamamoto Y., Wada O., Suzawa M., Yogiashi Y., Yano T., Kato S., and Yanagisawa J. The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. J. Biol. Chem. 276 (2001) 42684-42691
18. Zhang S., and Danielsen M. 8-Br-cAMP does not convert antagonists of the glucocorticoid receptor into agonists. Recent Prog. Horm. Res. 50 (1995) 429-435